Linked Life Data

15351492

Source:http://linkedlifedata.com/resource/pubmed/id/15351492

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15351492rdf:typepubmed:Citationlld:pubmed
pubmed-article:15351492lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:15351492lifeskim:mentionsumls-concept:C0442118lld:lifeskim
pubmed-article:15351492lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:15351492lifeskim:mentionsumls-concept:C2076600lld:lifeskim
pubmed-article:15351492lifeskim:mentionsumls-concept:C0027964lld:lifeskim
pubmed-article:15351492pubmed:issue2lld:pubmed
pubmed-article:15351492pubmed:dateCreated2004-9-7lld:pubmed
pubmed-article:15351492pubmed:abstractTextLive, cold-adapted, temperature-sensitive (ca/ts) Russian influenza A vaccines are prepared in eggs by a 6:2 gene reassortment of the ca/ts donor strain A/Leningrad/134/17/57 (H2N2) (Len/17) with a current wild-type (wt) influenza A strain contributing hemagglutinin (HA) and neuraminidase (NA) genes. However, egg-derived reassortant vaccines are potentially more problematic to manufacture in large quantities than vaccines from cell-based procedures. To compare egg- and cell culture-derived reassortant vaccines, we prepared in Madin Darby canine kidney (MDCK) cells two cloned, ca/ts reassortants (25M/1, 39E/2) derived from Len/17 and a wt reference strain A/New Caledonia/20/99 (H1N1) (NC/wt). Both 25M/1 and 39E/2 reassortants preserved the ca/ts phenotype and mutations described for internal genes of the A/Len/17 parent. When compared to a commercial, egg-derived ca/ts Russian A/17/NC/99/145 (H1N1) New Caledonia vaccine (NC/145), the MDCK-derived reassortant 39E/2 vaccine conferred similar levels of protection in ferrets challenged i.n. with 7 x 10(10) pfu of NC/wt. In a dose-ranging study, the protective vaccine dose for 50% of ferrets (PD50) was less than 1.2 x 10(4) pfu for the 25M/1 vaccine derived by recombination and amplification in MDCK cells. Clonal isolates of ca/ts influenza A/New Caledonia/20/99 (H1N1) obtained by recombination and amplification entirely in MDCK cells can be highly protective i.n. vaccines.lld:pubmed
pubmed-article:15351492pubmed:languageenglld:pubmed
pubmed-article:15351492pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351492pubmed:citationSubsetIMlld:pubmed
pubmed-article:15351492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15351492pubmed:statusMEDLINElld:pubmed
pubmed-article:15351492pubmed:monthOctlld:pubmed
pubmed-article:15351492pubmed:issn0168-1702lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:YouilRimaRlld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:MR GRGlld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:KiselevaIrina...lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:ShawAlanAlld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:SzymkowiakChr...lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:KwanWan-SangW...lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:RudenkoLarisa...lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:PalkerThomasTlld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:JohnstonKimbe...lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:TonerTimothyTlld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:RubinBorisBlld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:PetrukhinLuba...lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:WlochowskiJoa...lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:MonteiroJuani...lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:KraiouchkineN...lld:pubmed
pubmed-article:15351492pubmed:authorpubmed-author:DiStefanoDani...lld:pubmed
pubmed-article:15351492pubmed:issnTypePrintlld:pubmed
pubmed-article:15351492pubmed:volume105lld:pubmed
pubmed-article:15351492pubmed:ownerNLMlld:pubmed
pubmed-article:15351492pubmed:authorsCompleteYlld:pubmed
pubmed-article:15351492pubmed:pagination183-94lld:pubmed
pubmed-article:15351492pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:meshHeadingpubmed-meshheading:15351492...lld:pubmed
pubmed-article:15351492pubmed:year2004lld:pubmed
pubmed-article:15351492pubmed:articleTitleProtective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.lld:pubmed
pubmed-article:15351492pubmed:affiliationDepartment of Virus and Cell Biology, Vaccine and Biologics Research, Merck Research Laboratories, Merck and Co., Inc., 770 Sumneytown Pike, WP16-101, West Point, PA 19486, USA. tom_palker@merck.comlld:pubmed
pubmed-article:15351492pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15351492lld:pubmed